StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Dare Bioscience's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.29M. For fiscal 2025 it was -$9.89M, down 280.6% from the year before. The highest annual figure on record is $5.47M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.89M-280.6%
FY2024Dec 31, 2024$5.47M–
FY2023Dec 31, 2023-$38.86M–
FY2022Dec 31, 2022-$18.09M–
FY2021Dec 31, 2021-$28.76M–
FY2020Dec 31, 2020-$25.23M–
FY2019Dec 31, 2019-$13.32M–
FY2018Dec 31, 2018-$10.27M–
FY2017Dec 31, 2017-$2.54M–
FY2016Dec 31, 2016-$372.30K–
FY2015Dec 31, 2015-$31.92M–
FY2014Dec 31, 2014-$19.06M–
FY2013Dec 31, 2013-$16.61M–
FY2012Dec 31, 2012-$21.01M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.78M–
Q1 FY2026Mar 31, 2026-$5.52M–
Q4 FY2025Dec 31, 2025$1.44M-72.8%
Q3 FY2025Sep 30, 2025-$442.14K–
Q2 FY2025Jun 30, 2025-$5.42M-142.0%
Q1 FY2025Mar 31, 2025-$5.47M–
Q4 FY2024Dec 31, 2024$5.31M–
Q3 FY2024Sep 30, 2024-$5.92M–
Q2 FY2024Jun 30, 2024$12.90M–
Q1 FY2024Mar 31, 2024-$6.81M–
Q4 FY2023Dec 31, 2023-$8.18M–
Q3 FY2023Sep 30, 2023-$7.97M-192.7%
Q2 FY2023Jun 30, 2023-$6.59M–
Q1 FY2023Mar 31, 2023-$16.12M–
Q4 FY2022Dec 31, 2022-$5.90M–
Q3 FY2022Sep 30, 2022$8.60M+551.4%
Q2 FY2022Jun 30, 2022-$8.45M–
Q1 FY2022Mar 31, 2022-$12.34M–
Q4 FY2021Dec 31, 2021-$9.92M–
Q3 FY2021Sep 30, 2021$1.32M–
Q2 FY2021Jun 30, 2021-$11.79M–
Q1 FY2021Mar 31, 2021-$8.38M–
Q4 FY2020Dec 31, 2020-$9.19M–
Q3 FY2020Sep 30, 2020-$5.36M–
Q2 FY2020Jun 30, 2020-$4.09M–
Q1 FY2020Mar 31, 2020-$6.60M–
Q4 FY2019Dec 31, 2019-$3.81M–
Q3 FY2019Sep 30, 2019-$3.18M–
Q2 FY2019Jun 30, 2019-$3.02M–
Q1 FY2019Mar 31, 2019-$3.31M–
Q4 FY2018Dec 31, 2018-$2.71M–
Q3 FY2018Sep 30, 2018-$2.75M–
Q2 FY2018Jun 30, 2018-$2.69M–
Q1 FY2018Mar 31, 2018-$2.12M–
Q4 FY2017Dec 31, 2017-$961.07K–
Q3 FY2017Sep 30, 2017-$1.42M-105.8%
Q2 FY2017Jun 30, 2017-$109.61K–
Q1 FY2017Mar 31, 2017-$50.60K–
Q4 FY2016Dec 31, 2016-$166.95K–
Q3 FY2016Sep 30, 2016$24.30M–

More Dare Bioscience figures

See a number that looks wrong?